3 Results for "

zandelisib

" in MedChemExpress (MCE) Product Catalog:
Products (3)

3 Results for "zandelisib" in MCE Product Catalog:

Zandelisib
Zandelisib
0 Images
Referencia número: HY-109198
No. CAS: 1401436-95-0
Pureza:  99.90%
Synonyms: ME-401; PWT-143
Target:  

PI3K Akt

Áreas de investigación:  

Cancer

Zandelisib (ME-401) is a selective, orally active, non-covalent inhibitor of PI3Kδ. Zandelisib can sustainably inhibit AKT phosphorylation and downstream signaling pathways. Zandelisib can be used in the study of malignancies such as relapsed/refractory B-cell lymphoma .
Zandelisib hydrochloride
Zandelisib hydrochloride
0 Images
Referencia número: HY-109198A
No. CAS: 2839515-65-8
Synonyms: ME-401 hydrochloride; PWT-143 hydrochloride
Target:  

PI3K Akt

Áreas de investigación:  

Cancer

Zandelisib (ME-401) hydrochloride is a selective, orally active, non-covalent inhibitor of PI3Kδ. Zandelisib hydrochloride can sustainably inhibit AKT phosphorylation and downstream signaling pathways. Zandelisib hydrochloride can be used in the study of malignancies such as relapsed/refractory B-cell lymphoma .
Zandelisib (Standard)
Zandelisib (Standard)
0 Images
Referencia número: HY-109198R
No. CAS: 1401436-95-0
Synonyms: ME-401 (Standard); PWT-143 (Standard)
Target:  

Reference Standards PI3K Akt

Áreas de investigación:  

Cancer

Zandelisib (Standard) is the analytical standard of Zandelisib (HY-109198). This product is intended for research and analytical applications. Zandelisib (ME-401) is a selective, orally active, non-covalent inhibitor of PI3Kδ. Zandelisib can sustainably inhibit AKT phosphorylation and downstream signaling pathways. Zandelisib can be used in the study of malignancies such as relapsed/refractory B-cell lymphoma .
Assay Types